Our group has reported that nuclear IGF-1R is detectable in pre-invasive lesions and several types of invasive malignancy including prostate, renal and breast cancers, and is associated with adverse prognosis in renal cancer and advanced tumor stage in prostate cancer [61,63]. The gene discussed is IGF1R; the disease is neoplasm.